Schneider to Assume New Role as Honorary Vice Chair DALLAS, TX– August 21, 2025 – Susan G. Komen®, the world’s leading breast cancer organization, today announced that President and Chief Executive Officer Paula Schneider has shared that she will step down from the CEO role after seven years of transformational leadership. Schneider will continue to […]

Community Event to Support People with Breast Cancer, Raise Funds for Research and Advocacy Takes Place September 13, 2025 Susan G. Komen®, the world’s leading breast cancer organization, will convene breast cancer survivors, those living with metastatic breast cancer (MBC) and supporters at the 2025 Susan G. Komen Detroit Race for the Cure. This impactful […]

Popular Events Like the 3-Day, Race for the Cure, and MORE THAN PINK Walk Bring People Together to Support Patients and Fund Lifesaving Research and Public Policy efforts Susan G. Komen®, the world’s leading breast cancer organization, is bringing its signature fundraising events to 37 cities nationwide this fall—uniting communities through the Susan G. Komen […]

Bills support critical investments in breast cancer research and safety-net programs Yesterday, the Senate Appropriations Committee advanced two bills setting funding levels for programs within the Departments of Defense (DoD) and Health and Human Services (HHS) for fiscal year 2026 (FY26). Susan G. Komen’s Center for Public Policy commends the Committee for rejecting devastating cuts […]

AUGUSTA – Susan G. Komen®, the world’s leading breast cancer organization, issued the following statement on the passage of LD 178, legislation that expands the prohibition of step therapy protocols for metastatic cancer patients. Step therapy, also referred to as “fail first,” requires a patient to first try a health plan preferred drug, have that […]

Breast cancer patients face devastating consequences for access to critical breast cancer care Susan G. Komen®, the world’s leading nonprofit breast cancer organization, is deeply troubled by passage of the One Big Beautiful Bill Act which implements damaging reforms to federal health insurance programs. The Congressional Budget Office estimates these changes, combined with the failure […]

Court Decision Maintains Insurance Coverage of Screening Mammograms, Genetic Testing, and Medications to Lower Breast Cancer Risk with No Patient Cost  WASHINGTON, DC – Susan G. Komen®, the world’s leading breast cancer organization, commends the United States Supreme Court’s decision to overturn a lower court decision that threatened access to preventive breast care services, including […]

Grants Drive Lifesaving Advances in Metastatic Research, Precision Medicine and Health Equity As Funding Challenges Grow DALLAS – Susan G. Komen®, the world’s leading breast cancer organization, announced today that it is awarding $10.8 million in new research grants that will help propel innovative science and deliver hope to those facing the disease. These research […]

Susan G. Komen® Applauds Bill Introductions, Urges Quick Passage MADISON, WISCONSIN – MAY 22, 2025 – Susan G. Komen®, the world’s leading breast cancer organization commends Representative Cindi Duchow (R–Delafield) and Senator Rachael Cabral-Guevara (R–Appleton) for introducing legislation to ensure that everyone has equitable access to diagnostic and supplemental breast imaging, by eliminating the financial […]

Breast cancer patients could lose coverage, face delays in critical care DALLAS, TEXAS – May 22, 2025 – Susan G. Komen®, the world’s leading nonprofit breast cancer organization, is deeply troubled by passage of legislation by the House of Representatives which drastically cuts funding for federal health insurance programs and implements damaging reforms. The Congressional […]

ANNAPOLIS, MARYLAND – MAY 21, 2025 – Susan G. Komen®, the world’s leading breast cancer organization, today issued the following statement on the passage of critical legislation that expands the prohibition of step therapy protocols for metastatic cancer patients to further include associated conditions caused by the side effects of the patient’s cancer treatment, SB […]

Susan G. Komen® Applauds Bill Introduction, Urges Quick Passage COLUMBUS, OHIO – MAY 21, 2025 – Susan G. Komen®, the world’s leading breast cancer organization commends Representatives Jean Schmidt (R-Loveland) and Josh Williams (R-Sylvania Township) for introducing legislation to ensure that everyone has equitable access to diagnostic and supplemental breast imaging, by eliminating the financial […]